Navigation Links
Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
Date:11/12/2007

PARIS, November 12 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, today announced that Bristol-Myers Squibb Company (NYSE: BMY) has renewed its license to Aureus' AurSCOPE GPCR, and has also licensed Aureus' AurSCOPE Kinase and Ion Channel Knowledge databases.

Aureus Pharma's target-family-based AurSCOPE knowledge databases contain quantitative biological activity data which has been mined from the scientific literature. By understanding existing structure activity relationships, and the overall pharmacological space associated with a target/ligand, researchers can better design and prioritize experiments.

"We are very pleased that Bristol-Myers Squibb has chosen Aureus Pharma as a partner for knowledge based drug discovery," commented Jason Theodosiou, CEO of Aureus Pharma. "Bristol-Myers Squibb has been an important customer since 2002 and we regard their renewal and license extension as confirmation that our knowledge database solutions are meeting the needs of the world's leading pharmaceutical companies."

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus accelerates drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharma topics including ADME/Drug-Drug Interactions and the hERG Channel. The data contained in the Aureus Pharma system is of importance to aid in lead
'/>"/>

SOURCE Aureus Pharma
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 WriteResult, LLC – a premier ... again shown superiority when it comes to meeting the ... ePRO portion of their most recent study closeout on-time ... chose WriteResult’s digital writing platform to collect Patient Reported ... to complete drew data from a number of assessments ...
(Date:8/26/2014)... An analysis by Replikins, Ltd. of Pubmed ... CoV virus strains has revealed extensive conservation and ... conservation and sharing of specific Replikin gene structures has ... as it did for the H5N1 influenza vaccine and ... been found to be effective (1,2). ...
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... virus strains in Pubmed, has revealed extensive conservation and ... conservation and sharing of specific Replikin gene structures has ... as it did for the H5N1 influenza vaccine and ... been found to be effective (1,2). ...
(Date:8/26/2014)... Vycom announced today that Modutek Corporation ... equipment, has selected its Flametec materials for a ... Beams (FRIB). This involved the creation of a ... Flametec PVC-C and Kytec PVDF material to clean superconducting ... linear accelerator (known as LINAC). , ...
Breaking Biology Technology:A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3
... economic growth. , ,Six months ago I wrote ... Article Knocks the Rust Off State Manufacturing Outlook, that recounted ... an interview from a December edition of Barrons Magazine. In ... U.S. recovery in a quarter of a century and that ...
... Medical Systems has announced that its Vericis system ... terabytes of storage for digital cardiovascular images and other ... years worth of study results, which clinicians will be ... over the Web from outreach clinics. In such a ...
... so- called social networks, services such as LinkedIn, Spoke, and ... "I'm LinkedIn - Now What," and they have questioned the ... wasn't being critical, really; I just didn't see a clear ... in recent weeks, I've experienced one "a-ha" moment after another, ...
Cached Biology Technology:Hey Willie, Wisconsin Manufacturing Doesnt Need an Aid Concert! 2Hey Willie, Wisconsin Manufacturing Doesnt Need an Aid Concert! 3Social networks and my big a-ha 2Social networks and my big a-ha 3Social networks and my big a-ha 4
(Date:8/27/2014)... Now that health advocates, campaigns against trans-fats have ... additive, they,re taking aim at sugar for its ... and policymakers are still wrangling over the best ... according to an article in Chemical & ... of the American Chemical Society. , In the ...
(Date:8/27/2014)... the main factors thought to be associated with ... are the age of the patient, mechanism of ... time, repair method, operation technique, and repair materials. ... repair of peripheral nerve injuries, there is no ... prognosis, and the dose-effect relationship of the predictors ...
(Date:8/27/2014)... Complex of fires had consumed 24,939 acres of land ... as of eight hours ago. , Lightning strikes ... of the Klamath National Forest when a thunderstorm passed ... three of those fires are now 100 percent contained. ... their size at containment: Delta, 150 acres; Sutcliffe, 27 ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2
... Inherited diseases such as cystic fibrosis can be caused ... cells make proteins. David Bedwell, Ph.D., a professor in ... Microbiology, says scientists are now closer to producing drugs ... of genetic disease. Bedwell is a renowned researcher ...
... , ANAHEIM, CA: Can eating less be as simple as ... According to a team of researchers from Cornell University, it can. ... Calif., researchers led by Brian Wansink, director of the Cornell Food ... study of 78 adults. "We looked at whether serving ...
... of monitor lizard, a close relative of the Komodo dragon, ... by a professor at UC Santa Barbara and a researcher ... of Ecology, Evolution and Marine Biology at UCSB, and Valter ... Finland, are the first to describe the distinctive lizard, which ...
Cached Biology News:Drug may treat cystic fibrosis, other diseases caused by 'nonsense mutations,' UAB researcher says 2New monitor lizard discovered in Indonesia 2